Home » Topics » Regulatory

Regulatory
RSS

Increlex approved for short stature caused by severe primary IGF-1 deficiency

Sep. 1, 2005

Actoplus Met approved for type 2 diabetes

Aug. 31, 2005

Taxotere approved for endometrial cancer in Japan

Aug. 24, 2005

Singulair approved for symptoms of perennial allergic rhinitis

Aug. 23, 2005

Diovan approved for high-risk heart attack survivors

Aug. 8, 2005

Celebrex approved for ankylosing spondylitis

Aug. 3, 2005

Japanese approval for Finibax

July 29, 2005

New Adderall XR approval extends use to adolescents

July 26, 2005

Rozerem receives FDA approval for insomnia

July 26, 2005

Retisert launched for chronic noninfectious uveitis

July 6, 2005